Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
OH THE HUMANITY, YOUR TICKET IS BROKEN! THE LOW WAS .83, AND IT WAS THERE FOR LESS THAN 5 MINUTES.
It means nothing. If it was adjusted for volume, it would be able to tell us how many shares move the price by how many points. But since it isn't, it's worthless.
I disagree with the entire premise of your post. At 90c a share, it really is cheap. The potential for this stock is enormous. The shadiness is the only false thing about the company. The managers have proven themselves to be world class inventors and scientists. Their skills at the negotiating table may leave something to be desired, but the science and the opinions of world class oncology doctors show that you're wrong.
Don't worry, 236T568, we closed at .86, and actually beat the Dow (they fell 1.5% today.
.82 was the low of the day, it was there for 5 whole minutes. It's now at .85 JIMMINY JILLICKERS!
WHY PVCT IS HEADED NOWHERE NEAR $.50.
For a response to this garbage, check out Dr. Alan Ross. He cites his work, explains his background, and is an acknowledged expert in his field: Dr. Ross's blog
For a much better response to this garbage than mine, check out Dr. Alan Ross: Alan Ross's blog here
It looks like we finally agree on something. Management may not be the right team to execute this, but they were smart enough to get patents, and the product itself is groundbreaking. I, too, can cherrypick from the article, even ignoring the fact that the quotes you chose has words like "seemingly", and "insinuated", which mean that they are NOT facts, just conjecture:
"Although there has been no direct link between PVCT management and any price manipulation campaign, the inference has remained."
"However, there are some very strong reasons that counter these concerns. If management is the primary concern (as it appears to be) then the primary catalyst to purchase the stock would be ownership of PV-10 itself. We should be clear here: PV-10 is an exciting drug. There are numerous peer reviewed articles and poster presentations at oncology conferences that dispel any concern regarding the legitimacy of the drug itself: it is for real, and it is not a scam."
"Adding to this reality is that fact that the drug is based on a Rose-Bengal solution. Rose-Bengal has been around for quite some time (though never before used to treat cancer), and it has not shown any significant negative side-effects to humans. This means, of course, that it is very unlikely that PV-10 will fail due to the discovery of negative side effects in human trials."
"Also, PV-10 is on the doorstep of enrolling for Phase III trials. The overall success rate for cancer drugs in Phase III is around 80% (which is quite a bit higher than the 64% achieved by other types of drugs). There is around a 90% probability once a drug completes Stage III that it will be marketed and sold."
MAKE THAT 15 CENTS!
UP 5 CENTS SO FAR TODAY WOOPIE YAY YAY YAY YAY
When framed that way, no it is not. When framed as THE SKY IS FALLING AHH OMG EVERYONE PANIC! Yes, it is.
Yes, it is. Considering that they just freed up MILLIONS of dollars, the fact that they paid $1m means nothing. You realize pharmaceutical companies are allowed to make more than one deal, right?
This is completely irrelevant.
Can you post a link or an article that makes you feel that way? I'd like to see something like that. I seem to only be able to find peer reviewed articles from prestigious institutions that talk about how revolutionary PV-10 is.
I guess only time will tell, but the data we've seen published recently certainly refutes your claims, at least in my opinion. Having faith in the drug does not mean that I have faith in the management team.
Except you're wrong. It ended at .87. Either way, it's a great buying opportunity if you believe in the science, which most here do. It'll hit $2.00 before it hits $.02, unfortunately for shorters.
Over 5 months old. What's the relevance?
Not the lowest! All liars and scummy cheaters take that!
What's the next step after the FDA commenting period on the filed P3 protocols?
Great news everyone, today was not the lowest average share price of the month!
Color me surprised, that actually was a useful link. Can we add that to the sticky post with useful links please?
Where else do people go for info on PVCT? I like the connecting the dots blog and the facebook group. Anywhere else that anyone recommends?
236T568,
How do you feel about the posters from Moffit and MD Anderson? What about the Phase 3 protocols?
Oh my... .93 and RISING!
It dropped 1 cent. Let's wait until the end of the day before freaking out, shall we?
Can this be added to the stickied post with links? Here is the company's rebuttal to the Pumpstopper article highlighting which parts are lies:
http://finance.yahoo.com/news/provectus-biopharmaceuticals-inc-refutes-inaccuracies-180800786.html
Here is an interview with the CFO and CTO refuting more lies:
http://seekingalpha.com/article/2256643-provectus-management-responds-to-accusations
It has been refuted. Note that the article is written by an anonymous and admitted short seller. He doesn't want to put his name on it so it cannot be tied back to him. The practice is widely used by scumbags with an anti-pvct agenda, including on message boards ( ). You shouldn't believe everything you read on the internet.
How about a post to useful links for new investors interested in PVCT, like the connecting the dots blog, links to the posters Moffit releases, MD Anderson white papers, things like that?
Can you explain why you feel that way? What DD have you done that points in that direction? Everything I've seen has been reputable journals putting out favorable results. Please provide any links you can, I'd be extremely curious to see the opposing point.
Mods, can we have this post stickied as well, as a counterpoint?
How do you feel about the recent institutional holders update? Vanguard with almost 3 million shares sounds like a big buyer to me.